These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 31823839)

  • 21. Prokinetic agents and laryngopharyngeal reflux disease: Prokinetic agents and laryngopharyngeal reflux disease: a systematic review.
    Glicksman JT; Mick PT; Fung K; Carroll TL
    Laryngoscope; 2014 Oct; 124(10):2375-9. PubMed ID: 24782414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of hyaluronic acid, dermatan sulphate, heparan sulphate and chondroitin 4/6 sulphate in human dermis, and a material of reference.
    Poulsen JH; Cramers MK
    Scand J Clin Lab Invest; 1982 Nov; 42(7):545-9. PubMed ID: 6218602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-acid diet for recalcitrant laryngopharyngeal reflux: therapeutic benefits and their implications.
    Koufman JA
    Ann Otol Rhinol Laryngol; 2011 May; 120(5):281-7. PubMed ID: 21675582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the effects of Viscoat and Healon on postoperative intraocular pressure.
    Hoffer KJ
    Am J Ophthalmol; 1986 Mar; 101(3):389. PubMed ID: 3953744
    [No Abstract]   [Full Text] [Related]  

  • 25. New aspects in the pathomechanism and diagnosis of the laryngopharyngeal reflux-clinical impact of laryngeal proton pumps and pharyngeal pH metry in extraesophageal gastroesophageal reflux disease.
    Becker V; Drabner R; Graf S; Schlag C; Nennstiel S; Buchberger AM; Schmid RM; Saur D; Bajbouj M
    World J Gastroenterol; 2015 Jan; 21(3):982-7. PubMed ID: 25624734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mixture of hyaluronic acid, chondroitin 6 sulphate and dermatan sulphate used to completely regenerate bone in rat critical size defect model.
    Zanchetta P; Lagarde N; Uguen A; Marcorelles P
    J Craniomaxillofac Surg; 2012 Dec; 40(8):783-7. PubMed ID: 22464550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Editorial comment to Restoring the glycosaminoglycans layer in recurrent cystitis: experimental and clinical foundations.
    Yazawa S
    Int J Urol; 2014 Aug; 21(8):769. PubMed ID: 24650253
    [No Abstract]   [Full Text] [Related]  

  • 28. Nissen fundoplication
    Zhang C; Hu ZW; Yan C; Wu Q; Wu JM; Du X; Liu DG; Luo T; Li F; Wang ZG
    World J Gastroenterol; 2017 May; 23(19):3546-3555. PubMed ID: 28596691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A 61-Year-Old Woman with Chronic Iron-Deficiency Anemia Due to a Cameron Lesion and a Response to Oral Application of Combined Poloxamer 407 with Hyaluronic Acid and Chondroitin Sulfate Following Single Treatment with Pantoprazole: A Case Report.
    Iliev IE; Loidl A
    Am J Case Rep; 2021 Jan; 22():e928021. PubMed ID: 33473099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pepsane-R administration in the treatment of gastroesophageal reflux disease].
    Loranskaia ID; Rakitskaia LG; Mamedova LD; Vishnevskaia VV; Malakhova EV
    Eksp Klin Gastroenterol; 2008; (4):78-82. PubMed ID: 19145906
    [No Abstract]   [Full Text] [Related]  

  • 31. [A comparative analysis of intravesical sodium hyaluronate monotherapy and its combination with oral chondroitin sulfate in patietns with bladder pain syndrome/intersticial cystitis].
    Aboyan IA; Aboyan VE; Pavlov SV; Zinkovskaya OV; Pavlov DS
    Urologiia; 2019 Apr; (1):35-39. PubMed ID: 31184015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Administration of hyaluronic acid and chondroitin-4-sulfate limits endogenous antioxidant depletion and reduces cell damage in experimental acute pancreatitis.
    Campo GM; Avenoso A; Campo S; Ferlazzo AM; Calatroni A
    Pancreas; 2004 Mar; 28(2):E45-53. PubMed ID: 15028960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simultaneous laryngopharyngeal pH monitoring (Restech) and conventional esophageal pH monitoring-correlation using a large patient cohort of more than 100 patients with suspected gastroesophageal reflux disease.
    Fuchs HF; Müller DT; Berlth F; Maus MK; Fuchs C; Dübbers M; Schröder W; Bruns CJ; Leers JM
    Dis Esophagus; 2018 Oct; 31(10):. PubMed ID: 29534167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systematic Review and Meta-Analysis of Intravesical Hyaluronic Acid and Hyaluronic Acid/Chondroitin Sulfate Instillation for Interstitial Cystitis/Painful Bladder Syndrome.
    Pyo JS; Cho WJ
    Cell Physiol Biochem; 2016; 39(4):1618-25. PubMed ID: 27627755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rethinking the laryngopharyngeal reflux treatment algorithm: Evaluating an alternate empiric dosing regimen and considering up-front, pH-impedance, and manometry testing to minimize cost in treating suspect laryngopharyngeal reflux disease.
    Carroll TL; Werner A; Nahikian K; Dezube A; Roth DF
    Laryngoscope; 2017 Oct; 127 Suppl 6():S1-S13. PubMed ID: 28842999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Role of slow-acting anti-arthritic agents in osteoarthritis (chondroitin sulfate, glucosamine, hyaluronic acid)].
    Aubry-Rozier B
    Rev Med Suisse; 2012 Mar; 8(332):571-2, 574, 576. PubMed ID: 22455150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemiluminescence high-performance liquid chromatography for the determination of hyaluronic acid, chondroitin sulphate and dermatan sulphate.
    Akiyama H; Shidawara S; Mada A; Toyoda H; Toida T; Imanari T
    J Chromatogr; 1992 Sep; 579(2):203-7. PubMed ID: 1429967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Composite pH predicts esomeprazole response in laryngopharyngeal reflux without typical reflux syndrome.
    Lien HC; Wang CC; Liang WM; Sung FC; Hsu JY; Yeh HZ; Chong K; Chang CS
    Laryngoscope; 2013 Jun; 123(6):1483-9. PubMed ID: 23553459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical comparison of intravesical hyaluronic acid and chondroitin sulfate therapies in the treatment of bladder pain syndrome/interstitial cystitis.
    Gülpınar Ö; Esen B; Kayış A; Gökçe Mİ; Süer E
    Neurourol Urodyn; 2018 Jan; 37(1):257-262. PubMed ID: 28480984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of refractory interstitial cystitis/painful bladder syndrome with CystoProtek--an oral multi-agent natural supplement.
    Theoharides TC; Kempuraj D; Vakali S; Sant GR
    Can J Urol; 2008 Dec; 15(6):4410-4. PubMed ID: 19046494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.